SciVal Spotlight Gaining Momentum Across the Globe as More Universities Seek Multidisciplinary View of Research Performance

Multiple Leading Institutions Purchase New Strategic Decision-Support Tool

AMSTERDAM, December 8 - Elsevier, a world-leading publisher of scientific, technical and medical
information products and services, today announced that several universities
have purchased its new SciVal Spotlight tool. The institutions, including
National Chiao Tung University (Taiwan), St. Petersburg University (Russia),
University of Stellenbosch (South Africa) and the University of Vigo (Spain),
will use the tool to analyze current output in order to enhance their near
and long term research strategies.

SciVal Spotlight is a customizable web-based tool that offers
institutions a multidisciplinary perspective of research performance. Using
an innovative visualization technique, the tool produces customized maps that
provide graphical views of an institution's research output over time and
across scientific fields, focusing on specific topical areas.

"We've selected SciVal Spotlight to help us understand our competitive
strengths as well as assist us in making the best possible investments for
our university," said Chain-Shu Hsu, Vice President of National Chiao Tung
University. "We are excited about the tailored insight the tool can offer and
its ability to give us a better understanding of our position in the global
research landscape."

"By pinpointing a university's topical strengths and identifying leading
researchers and institutions in each area, SciVal Spotlight is designed to
help academic decision-makers optimize funding allocations and enhance hiring
and collaboration decisions," said Helen de Mooij, Academic & Government
Products Group, Elsevier. "We are pleased at the interest we are seeing in
the market as universities recognize the value the tool can offer in
evaluating, establishing and executing research strategies."

About the Elsevier SciVal Suite

The SciVal suite of services delivers intelligence solutions to help the
academic and government research communities evaluate, establish and execute
their research strategies more effectively. The suite currently includes
SciVal Spotlight and SciVal Funding.

With traditional research performance measurement options unable to
capture the reality of today's multidisciplinary scientific landscape, the
SciVal Spotlight tool is designed to provide research managers with a more
accurate picture of any institution's unique research strengths and
opportunities.

SciVal Funding is an online funding intelligence solution that enables
researchers and research administrators to better compete for research
funding. The tool provides access to over 5,000 funding sources and includes
targeted recommendations based on pre-populated research profiles as well as
an extensive history of awarded grants.

For more information on the SciVal Suite, please visit
www.scival.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com) and Cell
(www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com),
Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and
Nursing Consult (www.nursingconsult.com), which enhance the
productivity of science and health professionals, and the SciVal suite
(www.scival.com) and MEDai's Pinpoint Review (www.medai.com),
which help research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Contact:
    Name: Jessica Disch
    Phone: +1-212-752-8338
    E-mail: jdisch@psbpr.com

Contact: Name: Jessica Disch, Phone: +1-212-752-8338, E-mail: jdisch at psbpr.com